AngioDynamics to Report Fiscal Third Quarter 2009 Financial Results and Hold Conference Call on April 2, 2009QUEENSBURY, N.Y.--(BUSINESS WIRE)--Mar. 24, 2009-- AngioDynamics, Inc.(NASDAQ:ANGO), a leading provider of innovative medical devices used by interventional radiologists, nephrologists and surgeons for the minimally invasive treatment of cancer and peripheral vascular disease, announced today that it will report its fiscal third quarter financial results on Thursday, April 2, 2009 after the close of the financial markets.

Jan Keltjens, president and chief executive officer, and Joseph Gersuk, executive vice president and CFO, will host an investment community conference call beginning at 4:30 p.m. Eastern time on April 2 to discuss these results and to answer questions.

To participate in the live call by telephone, please dial (800) 257-7087 from the U.S., or for international callers, please dial +1 (303) 262-2140.

Those interested in listening to the conference call live via the Internet may do so by visiting the Investor Relations section of AngioDynamics’ website at http://investor.angiodynamics.com. To listen to the live call, please go to the website 15 minutes prior to its start to register, download, and install the necessary audio software.

A replay will be available on the website. A telephone replay will be available from 6:30 p.m. Eastern time on April 2, 2009 through 11:59 p.m. Eastern time on April 9 by dialing (800) 405-2236 (domestic) or +1 (303) 590-3000 (international) and entering the passcode: 11128472#.

About AngioDynamics

AngioDynamics, Inc. is a leading provider of innovative medical devices used by interventional radiologists, nephrologists and surgeons for the minimally invasive treatment of cancer and peripheral vascular disease. The Company's diverse product line includes market-leading radiofrequency ablation and irreversible electroporation ablation systems, vascular access products, angiographic products and accessories, dialysis products, angioplasty products, drainage products, thrombolytic products, embolization products and venous products. More information is available at www.angiodynamics.com.

Source: AngioDynamics, Inc.

AngioDynamics, Inc.
D. Joseph Gersuk, CFO, 800-772-6446 ext. 1608
jgersuk@AngioDynamics.com
or
EVC Group, Inc.
Investor Relations:
Doug Sherk, 415-896-6820
dsherk@evcgroup.com
Jenifer Kirtland, 415-896-6820
jkirtland@evcgroup.com
Media:
Chris Gale, 646-201-5431
cgale@evcgroup.com